Pfizer Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Pfizer Ltd. from all sources in a single place.

Load latest

Pfizer Ltd.

11 Oct 2024

5150.50

2.27%

USFDA approves Pfizer's Hympavzi for rare bleeding disorder hemophilia

Business Standard

The drug, Hympavzi, is given under the skin through an auto-injector pen to prevent or reduce bleeding episodes in hemophilia A or B patients aged 12 years and older

Pfizer Ltd. is trading at high day volume of 288.4K.

Pfizer Ltd.

10 Oct 2024

5150.50

2.27%

Ex Pfizer CEO, CFO not to involve in Starboard's campaign on drugmaker

Business Standard

Pfizer's shares have fallen more than 9% in the past year and trade at around half of their pandemic-era highs as sales of its COVID products shrink

Pfizer Ltd. is trading below its 30 day SMA of 5200.5

Pfizer Ltd.

08 Oct 2024

5150.50

2.27%

Corp. Note

PFIZER LTD. - 500680 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate …

BSE India

Intimation regarding loss of share certificates and issue of Letter of Confirmation.

pdf

Pfizer Ltd.

08 Oct 2024

5150.50

2.27%

Company Update

PFIZER LTD. - 500680 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2024.

pdf

Pfizer Ltd.

07 Oct 2024

5150.50

2.27%

Activist investor Starboard Value acquires $1 billion stake in Pfizer

Business Standard

Read served as CEO until Albert Bourla took the position in 2019. Bourla was instrumental in working with BioNTech to develop a COVID-19 vaccine

Pfizer Ltd.'s price crossed above 100Day SMA today

Starboard Value takes $1 billion stake in Pfizer in activist push

Business Line | 07 Oct 2024 1 more

Pfizer Ltd.

02 Oct 2024

5150.50

2.27%

Corp. Note

PFIZER LTD. - 500680 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate …

BSE India

Intimation regarding loss of share certificates and issue of Letter of confirmation

pdf

Pfizer Ltd.

01 Oct 2024

5150.50

2.27%

Pfizer to further reduce stake in Haleon, offers to sell 540 million share

Business Standard

The US company intends to sell 540 million Haleon shares, according to a statement on Monday

Number of FII/FPI investors increased from 129 to 139 in Jun 2025 qtr.

Pfizer Ltd.

30 Sep 2024, 08:19PM

5150.50

2.27%

SAST

PFIZER LTD. - 500680 - Closure of Trading Window

BSE India

We would like to inform you that, for the purpose of declaration of unaudited financial results for the quarter and half year ending September 30, 2024, the trading window of the Company shall remain closed from Monday, September 30, 2024 (close of business) till 48 hours after the financial results are made public.

pdf

Pfizer Ltd.

18 Sep 2024

5150.50

2.27%

Pfizer launches Analytics Gateway' in India, its first dedicated global commercial analytics centre

Business Line

The centre is expected to accelerate data science and AI solutions to meet Pfizer's ambitions in modernising marketing and creating an agile sales force